Compounds > floxuridine
Page last updated: 2024-08-17

floxuridine and alprostadil

floxuridine has been researched along with alprostadil in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cruz, AB; Gaskill, HV; Kahky, MP; Lind, DS1
Carrasco, C; Charnsangavej, C; Faintuch, J; Levin, B; Mavligit, GM; Patt, YZ; Wallace, S1
Gaskill, HV1

Trials

1 trial(s) available for floxuridine and alprostadil

ArticleYear
Gastroduodenal mucosal injury during hepatic arterial infusion of chemotherapeutic agents. Lack of cytoprotection by prostaglandin E1 analogue.
    Gastroenterology, 1987, Volume: 92, Issue:3

    Topics: Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Double-Blind Method; Floxuridine; Gastric Mucosa; Hepatic Artery; Humans; Infusions, Intra-Arterial; Intestinal Mucosa; Liver Neoplasms; Misoprostol; Mitomycin; Mitomycins; Random Allocation

1987

Other Studies

6 other study(ies) available for floxuridine and alprostadil

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Prostaglandin E1 enhances tumoricidal activity of 5-fluoro-2'-deoxyuridine in rats.
    The Journal of surgical research, 1991, Volume: 51, Issue:2

    Topics: Adenocarcinoma; Alprostadil; Animals; Antineoplastic Agents; Body Weight; Drug Synergism; Floxuridine; Rats; Rats, Inbred F344

1991
Intraportal prostaglandin E1 ameliorates the toxicity of intraportal 2'-deoxy-5-fluorouridine in rats.
    The Journal of surgical research, 1987, Volume: 43, Issue:2

    Topics: Alprostadil; Animals; Body Weight; Floxuridine; Leukocyte Count; Male; Organ Size; Rats; Rats, Inbred Strains

1987